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Proximity biotinylation workflows typically require CRISPR-based genetic manipulation of
target cells. To overcome this bottleneck, we fused the TurboID proximity biotinylation
enzyme to Protein A. Upon target cell permeabilization, the ProtA-Turbo enzyme can be
targeted to proteins or post-translational modifications of interest using bait-specific anti-
bodies. Addition of biotin then triggers bait-proximal protein biotinylation. Biotinylated pro-
teins can subsequently be enriched from crude lysates and identified by mass spectrometry.
We demonstrate this workflow by targeting Emerin, H3K9me3 and BRG1. Amongst the main
findings, our experiments reveal that the essential protein FLYWCH1 interacts with a subset
of H3K9me3-marked (peri)centromeres in human cells. The ProtA-Turbo enzyme represents
an off-the-shelf proximity biotinylation enzyme that facilitates proximity biotinylation
experiments in primary cells and can be used to understand how proteins cooperate in vivo
and how this contributes to cellular homeostasis and disease.
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Proximity biotinylation recently emerged as a powerfulinteraction proteomics technology that can be used toidentify direct and indirect interactions between proteins
in vivo1–4. This technology typically involves fusing a proximity
biotinylation enzyme to target proteins of interest using CRISPR-
based knock-in strategies or plasmid-based expression. Upon the
addition of exogenous biotin, proteins that are in close proximity
to the bait protein during the biotin pulse become biotinylated.
These biotinylated proteins can subsequently be enriched from
crude cell lysates using streptavidin-conjugated beads and ana-
lyzed by quantitative mass spectrometry. Various proximity
biotinylation enzymes have been described, including BioID3,
BioID25, APEX6, and TurboID7. TurboID in particular is a very
attractive proximity biotinylation enzyme since it is a very fast
enzyme, which labels bait-proximal proteins in minutes. Fur-
thermore, unlike the APEX enzyme, which relies on H2O2 for its
enzymatic activity, TurboID-based proximity biotinylation only
requires exogenous addition of biotin to target cells and is
therefore not toxic for target cells.
Proximity biotinylation enzymes have been used for various
biological questions, for example for temporal profiling of DNA
damage response pathways, to decipher cellular signaling path-
ways and for organelle-specific proteome profiling in cell culture
cells and model organisms4,8–10. However, as mentioned above,
these approaches rely on CRISPR-based knock-in or plasmid-
based expression approaches to introduce a biotinylation enzyme
fused to a bait protein in target cells of interest. This is not only
labor-intensive but also restricts proximity biotinylation tech-
nology to cells that can be genetically engineered and maintained
and propagated for a long period of time in vitro. There is
therefore a need for technology to overcome this bottleneck and
that facilitates proximity biotinylation workflows in primary cells
in the absence of genetic engineering or transfection.
Here we present a recombinant proximity biotinylation enzyme,
called ProtA-Turbo, which consists of Protein A fused to the
TurboID proximity biotinylation enzyme. Upon target cell per-
meabilization using either fixed or non-fixed mammalian cells, the
ProtA-Turbo enzyme can be targeted to baits of interest using
antibodies against endogenous proteins or protein modifications.
Bait proximal proteins are subsequently biotinylated upon the
addition of exogenous biotin. Cells are then lysed using high
stringency lysis and biotinylated proteins are affinity enriched
using streptavidin-conjugated beads using appropriate negative
controls. Affinity enrichments are performed in triplicate to allow a
robust statistical analysis. To benchmark this method, we com-
bined the ProtA-Turbo enzyme with antibodies against various
well-characterized baits: Emerin, which resides in the nuclear
envelope, the heterochromatin modification H3K9me3 and the
chromatin remodeler protein BRG1, which is part of the Swi/Snf
complex, in various cell types. For all these baits, confocal micro-
scopy revealed that the ProtA-Turbo enzyme and associated bio-
tinylation are targeted to appropriate regions in mammalian nuclei.
Affinity purifications and label-free quantitative mass spectrometry
revealed numerous positive controls as well as previously unre-
ported proximal proteins for all the used baits. Finally, follow-up
experiments revealed that FLYWCH1 is an H3K9me3-associated
protein that interacts with H3K9me3-marked centromeric het-
erochromatin. In summary, the recombinant ProtA-Turbo enzyme
represents an ‘off the shelf’ proximity biotinylation enzyme that
can be used for interaction proteomics studies in fixed and non-
fixed primary cells or clinical samples.
Results
Off the shelf proximity labeling in fixed cells using ProtA-
Turbo enzyme. With the aim to design an ‘off the shelf’ proximity
biotinylation enzyme that does not require genetic manipulation or
transfection of target cells, we generated a construct consisting of
Protein A fused to the recently developed proximity biotinylation
enzyme TurboID7 (from now on referred to as ProtA-Turbo). The
TurboID enzyme is a much faster, modified version of the BioID
proximity biotinylation enzyme, which can biotinylate proximal
proteins inside cells in minutes. This ProtA-Turbo fusion protein
was expressed and purified as a His-tagged fusion protein from
bacteria (Supplementary Fig. 1a). Initial activity tests revealed that
the purified ProtA-Turbo enzyme efficiently triggers protein bioti-
nylation in bacterial cells in vivo (Supplementary Fig. 1b). Fur-
thermore, the ProtA-Turbo enzyme also triggers protein
biotinylation when added to mammalian cell extracts (Supple-
mentary Fig. 1c). We first developed a workflow for the ProtA-
Turbo enzyme in fixed cells (Fig. 1a). After formaldehyde-based
fixation, cells are permeabilized followed by subsequent addition of
a primary antibody and the ProtA-Turbo enzyme. An isotype
control IgG antibody is used as a negative control. Following several
wash steps to remove unbound antibodies and enzymes, the addi-
tion of exogenous biotin triggers bait-proximal protein biotinyla-
tion. These biotinylated proteins can subsequently be enriched from
crude cell lysates using streptavidin-based affinity enrichment and
identified using quantitative LC–MS.
To benchmark this method, we made use of antibodies against
various well-characterized nuclear baits: Emerin, BRG1, and a
histone modification, H3K9me3. Immunofluorescence-based analy-
sis revealed that ProtA-Turbo-mediated biotinylation using these
antibodies is induced in a pattern that is in agreement with the
known nuclear localization of the respective baits. For example, the
Emerin antibody, which resides in the nuclear envelope, triggers
ProtA-Turbo-mediated biotinylation in the nuclear rim, whereas the
H3K9me3 antibody results in a punctuated biotinylation signal in
the nucleus that is reminiscent of the DAPI-dense chromocenters in
mammalian nuclei, which are enriched for H3K9me3. In contrast,
the BRG1 antibody, which targets the large multi-subunit Swi/Snf
complex, results in a more diffuse nuclear staining (Fig. 1b).
Streptavidin-based affinity enrichment of ProtA-Turbo targeted cells
with these antibodies revealed efficient enrichment of the targeted
baits and associated protein biotinylation (Fig. 1c). Next, we
performed ProtA-Turbo experiments followed by streptavidin-
based affinity enrichment in triplicate (with each replicate starting
from an individual cell suspension) with the respective baits and
negative IgG controls followed by quantitative mass spectrometry
analyses. As shown in Fig. 1d and Supplementary Fig. 1e, each of the
three bait antibodies in combination with the ProtA-Turbo enzyme
resulted in a cluster of specifically enriched biotinylated proteins,
including many positive control proteins. For example, various
nuclear lamina-associated proteins are enriched in the Emerin
ProtA-turbo experiments, including TMPO, SUN2, and LMNB1/2.
As expected, the BRG1 antibody in combination with the ProtA-
Turbo enzyme-induced enrichment of numerous Swi/Snf complex
subunits such as ARID1A, BRD7 and SMARCC1. Finally, the
H3K9me3 antibody resulted in specific enrichment of the H3K9
methyltransferases EHMT1/2 and Suv39H1, various known
H3K9me3 reader proteins (i.e. CBX5, CBX1 and UHRF1), as well
as centromere-associated proteins (INCENP, CDCA8). Centromeres
are known to be enriched for the H3K9me3 modification. GO term
enrichment analyses for the different affinity purifications are in
agreement with this: membrane and nuclear pore-associated GO
terms are enriched in the Emerin experiment, Swi/snf subunits in
the BRG1-ProtA-Turbo enrichment and heterochromatin and
condensed chromosome terms are enriched in the H3K9me3
experiment (Supplementary Fig. 1d). As a control experiment, we
generated a knock-in cell line in which we fused Emerin to TurboID.
Immunofluorescence experiments revealed biotinylation signals in
this cell line at the nuclear rim (Supplementary Fig. 1f), similar to
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-25338-4
2 NATURE COMMUNICATIONS |         (2021) 12:5015 | https://doi.org/10.1038/s41467-021-25338-4 | www.nature.com/naturecommunications
what we observed when targeting ProtA-Turbo with an Emerin
antibody. Furthermore, biotin purifications of crude lysates from the
Turbo-Emerin knock-in cells revealed specific enrichment of many
known nuclear lamina-associated proteins, many of which were also
retrieved in the protA-Turbo Emerin targeting experiment (Supple-
mentary Fig. 1g–i). GO term enrichment analysis of the Emerin
proximity labeling experiments performed in this study are also in
excellent agreement with previous interaction proteomics experi-
ments targeting the nuclear lamina (Supplementary Fig. 1j).
To further illustrate the ability of our method to trigger
antibody-dependent, bait-specific biotinylation, we performed
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H3K9me3 or IgG targeting with ProtA-Turbo. This experiment
revealed biotinylated chromatin patterns that are significantly
overlapping with previously generated H3K9me3 ChIP-seq data
in the same target cells (Fig. 1e, f). Furthermore, a comparison of
our ProtA-Turbo–H3K9me3 interactome with a recently pub-
lished proteomics method called ChromID11, in which proximity
biotinylation is targeted to chromatin modifications using
modification-specific reader domains fused to a proximity
biotinylation enzyme, revealed that many H3K9me3-proximal
proteins are identified using both methodologies (Supplementary
Fig. 1k).
In summary, these experiments clearly validate and illustrate
the value of the ProtA-turbo enzyme as an off-the-shelf proximity
biotinylation enzyme in the absence of genetic manipulation or
transfection of target cells, at least in a workflow with fixed cells.
Off the shelf proximity labeling in non-fixed cells using ProtA-
Turbo. Next, to further expand the applicability of the ProtA-
Turbo enzyme, we set out to establish a workflow in which the
ProtA-Turbo enzyme is targeted to baits of interest in non-fixed
cells (Fig. 2a), using the same antibodies that were also used in
fixed cells (Emerin, BRG1 and H3K9me3). A clear advantage of
the omission of crosslinking is the availability of certain down-
stream applications, which are not possible on cross-linked
material. Furthermore, the protocol with non-fixed cells is less
labor-intensive and less starting material is required. To avoid
disruption of membrane structures during the procedure, we used
the mild detergent digitonin for cell permeabilization. Digitonin
is also used in recently developed epigenome profiling tools such
as CUT & RUN12. Immunofluorescence experiments in non-fixed
cells revealed expected biotinylation patterns using bait-specific
antibodies, although not as clear as observed when using fixed
cells (Fig. 2b). Subsequent streptavidin affinity enrichment of
crude lysates revealed bait-specific interactomes of high quality,
with many expected proteins and enriched GO terms (Fig. 2c, d;
Supplementary Fig. 2a).
Having established efficient off-the-shelf proximity biotinylation
strategies for the ProtA-Turbo enzyme in fixed and non-fixed cells,
we aimed to further demonstrate the broad applicability of the
ProtA-Turbo workflow. To this end, we performed H3K9me3-
targeting experiments in a breast cancer cell line (MCF7 cells) and in
myeloid leukemia cells (U937) (Supplementary Fig. 2b, c). These
experiments, using fixed and non-fixed cells, respectively, revealed a
range of known heterochromatin proteins, as well as many
overlapping but also distinct H3K9me3 proximal proteins in both
cell lines. We also performed ProtA-Turbo Emerin-targeting
experiments in primary material, namely low passage primary
human fibroblasts. This revealed correct biotinylation targeting of
the nuclear envelope as assessed using immunofluorescence
(Supplementary Fig. 2d). Subsequent mass spectrometry-based
analyses revealed many known nuclear envelope components, thus
demonstrating the applicability of the ProtA-turbo enzyme to
identify bait-proximal proteins in non-fixed, primary cells (Supple-
mentary Fig. 2e–g). Finally, we evaluated the applicability of the
ProtA-Turbo enzyme to study the effects of cellular perturbations.
To this end, we performed H3K9me3 ProtA-Turbo-targeting
experiments in wild-type mouse embryonic stem cells (ESCs) and
ESCs lacking Suv39h1/2, the two enzymes responsible for depositing
H3K9me3 on pericentromeric heterochromatin. As expected,
immunofluorescence-based analysis revealed a reduction of
H3K9me3 foci in Suv39h1/2 KO cells, indicative of a reduction of
H3K9me3 on pericentromeric heterochromatin in Suv39h1/2
knock-out cells compared to wild type cells (Supplementary Fig. 2h).
Importantly, Suv39h1/2 knock-out cells still contain significant levels
of H3K9me3, catalyzed by Setdb1/2 and Ehmt1/2. ProtA-Turbo
H3K9me3 targeting experiments in wild-type versus Suv39h1/2
knock-out cells confirmed a previously reported depletion of
pericentromeric H3K9me3-proximal proteins, including Suv420h2,
as well as other H3K9me3 reader proteins such as CDYL2 and
UHRF1 in Suv39h1/2 knock-out cells compared to wild-type cells
(Supplementary Fig. 2i), thus validating the applicability of our off-
the-shelf proximity labeling workflow to study dynamic proximal
proteomes upon cellular perturbations.
FLYWCH1 localizes to centromeric, H3K9me3-marked chro-
matin. ProtA-Turbo proximity biotinylation experiments
revealed many known and previously unknown proximal pro-
teins for the baits we investigated. As an example, in various
ProtA-Turbo H3K9me3 targeting experiments we identified
several unreported H3K9me3-proximal proteins and we con-
firmed some of these (RNF169, SENP1, and SENP7) by immu-
nofluorescence and western blot (Supplementary Fig. 3a–c). In
addition to these proteins, we identified FLYWCH1 as an
H3K9me3-proximal protein. FLYWCH1 contains five so-called
FLYWCH-type Zinc fingers, and has previously been identified as
a regulator of beta-catenin signaling and is associated with var-
ious malignancies13,14. Furthermore, a homozygous Flywch1
deletion is embryonic lethal in mice15. However, it is currently
unclear whether and how FLYWCH1 plays a role in chromatin-
related processes. To study FLYWCH1 in more detail, we
transiently expressed GFP-FLYWCH1 and we used CRISPR
technology to generate endogenous GFP and V5 FLYWCH1
knock-in cell lines (Supplementary Fig. 3d, e). Immuno-
fluorescence experiments revealed a strong overlap between
FLYWCH1 and H3K9me3 in mammalian nuclei, consistent with
ProtA-Turbo H3K9me3 proteomics experiments (Fig. 3a). Next,
we performed ChIP-seq analysis for FLYWCH1 in duplicate
using the cell line in which endogenous FLYWCH1 is tagged with
GFP and a V5 tag (Supplementary Fig. 3f). These experiments
revealed a significant genome-wide overlap between H3K9me3
and FLYWCH1 (Fig. 3b). DNA motif analyses amongst 451 high
confidence FLYWCH1-binding sites in the genome (Supple-
mentary Fig. 3g) revealed strong enrichment of simple repeats
(Fig. 3c, d). In addition, many strong FLYWCH1-binding sites in
Fig. 1 A ProteinA-TurboID fusion protein allows enrichment of proteins localized to a specific sub-nuclear compartment in cross-linked cells. a
Schematic outline of the method. b Immunofluorescence images of targeting the nuclear lamina (via Emerin), the SWI/SNF protein complex (via BRG1) or
(pericentromeric) heterochromatin (via H3K9me3) in crosslinked HeLa cells. IgG was used as a control antibody. Biotinylation (in green) overlapping the
antibody signal (in red) illustrates correct localization of the ProtA-Turbo fusion protein. Scale bars represent 10 µm (large panels) or 3 µm (small panels).
c Immunoprecipitation of biotinylated proteins after targeting (T) proteins as in (b). IgG was used as a control (C). d Volcano plot of mass spectrometry
analyses of biotin IPs as in (c). A selection of proteins known to localize to the targeted proteins are highlighted. In the H3K9me3 volcano plot, red dots
indicate writer/writer complexes and blue indicates known pericentromeric proteins. Protein names in white indicate potential streptavidin contaminants
(see also Source Data). x-axis represent the log2 fold change (FC) and the y-axis the −log10 p-value of comparing three IgG replicates with three specific
antibody replicates. e, f Biotin ChIP-seq after H3K9me3 or IgG targeting with ProtA-Turbo. Number of independent experiments performed: b 5 (IgG),
5 (Emerin), 2 (BRG1), 5 (H3K9me3); c 3 (Emerin), 2 (BRG1), 5 (H3K9me3); d 4 (Emerin), 1 (BRG1), 3 (H3K9me3), n= 3 replicates per independent
experiment; e 2. Source data are provided as a Source Data file.
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the genome are localized at centromeric heterochromatin, which
is known to be enriched for H3K9me3 (Supplementary Fig. 3h).
Given the observation that FLYWCH1 localizes to centromeric
regions throughout the cell cycle in vivo (indicated by INCENP
binding) (Supplementary Fig. 3e), and given the fact that these
regions are strongly enriched for H3K9me3, we investigated
whether FLYWCH1 is a reader protein for the H3K9me3 mod-
ification. However, H3K9me3 peptide pulldowns in crude nuclear
extracts indicated that FLYWCH1 does not interact with
H3K9me3 directly (Supplementary Fig. 3i). Next, we performed
DNA affinity purifications with several versions of putative
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Fig. 2 A ProteinA-TurboID fusion protein allows enrichment of protein localized to a specific sub-nuclear compartment in non-crosslinked cells.
a Schematic outline of the method. b Immunofluorescence images of targeting the nuclear lamina (via Emerin), the SWI/SNF protein complex (via BRG1),
or (pericentromeric) heterochromatin (via H3K9me3) in non-crosslinked HeLa cells. IgG was used as control antibody. Biotinylation (in green) overlapping
the antibody signal (in red) illustrates the correct localization of the ProtA-Turbo fusion protein. Scale bars represent 10 µm (large panels) or 3 µm (small
panels). c Immunoprecipitation of biotinylated proteins after targeting (T) proteins as in (b). IgG has used a control (C). d Volcano plot of mass
spectrometry analyses of biotin IPs as in (c). A selection of proteins known to localize to the targeted proteins is highlighted. In the H3K9me3 volcano plot,
red dots indicate writer/writer complexes, and blue indicates known pericentromeric proteins. Protein names in white indicate potential streptavidin
contaminants (see also Source Data). the x-axis represents the log2 fold change (FC) and the y-axis the −log10 p-value of comparing three IgG replicates
with three specific antibody replicates. Number of independent experiments performed: b 3 (IgG), 3 (Emerin), 2 (BRG1), 3 (H3K9me3); c 3 (Emerin),
2 (BRG1), 3 (H3K9me3); d 2 (Emerin), 1 (BRG1), 3 (H3K9me3), n= 3 replicates per independent experiment. Source data are provided as a Source
Data file.
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FLYWCH1 Biotin DAPI Merge
Fig. 3 ProtA-Turbo targeting of H3K9me3 reveals FLYWCH1 as a protein localized to (peri)centromeric heterochromatin. a Immunofluorescence of
FLYWCH1 antibody staining (left), FLYWCH1-GFP overexpression (middle) or GFP-signal of FLYWCH1 endogenously tagged with GFP (right). The large
panel is the merge, and the small panels are H3K9me3 (red), antibody/GFP signal (green), or DAPI (blue). Scale bars represent 3 µm. b Representative
screenshot of FLYWCH1-bound genomic regions as assessed by ChIP-seq. IgG was used as a control antibody. Gray markers indicate different repeat types
from the Repeatmasker. c Most enriched DNA motifs under 451 FLYWCH1-specific peaks. P-values were calculated using hypergeometric enrichment
calculations using HOMER. d Intersection of FLYWCH1 ChIP-seq reads with most enriched repeat types/sequences that are at least 10-fold differential
between FLYWCH1 and IgG ChIP-seq. e Immunofluorescence analyses of FLYWCH1 fused to miniTurboID. FLYWCH1 is visualized by staining the V5 tag
(red). Scale bars represent 10 µm in the large panels and 5 µm in the zoomed panels. f Volcano plot of mass spectrometry analyses of biotin IPs of
FLYWCH1-miniTurboID with biotin compared to wildtype HeLa cells incubated with biotin (n= 3). Protein names in white indicate potential streptavidin
contaminants (see also Source Data). Number of independent experiments performed: a 2; b 2; e 2; f 2, n= 3 replicates per independent experiment.
Source data are provided as a Source Data file.
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(Fig. 3b), which revealed specific FLYWCH1 binding compared
to scrambled versions of the motifs (Supplementary Fig. 3j).
Selective binding of FLYWCH1 to certain DNA sequences at
(peri)centromeric chromatin loci may explain the striking
chromosome-specific-binding pattern we observed for
FLYWCH1 using ChIP-seq and immunofluorescence.
To gain further insights into the function of the FLYWCH1
protein, we aimed to generate a knock-in cell line in which
FLYWCH1 is directly fused to a proximity biotinylation enzyme.
While efforts to generate a FLYWCH1-TurboID knock-in cell line
were unsuccessful, we obtained a cell line in which endogenous
FLYWCH1 is fused to miniTurboID, which is a smaller and less
active version of the TurboID enzyme.7 Immunofluorescence
experiments revealed that nuclear biotinylation in this FLYWCH1-
miniTurbo cell line is localized in punctuated foci, which is
consistent with the H3K9me3-staining pattern in mammalian cells
(Fig. 3e). Subsequent streptavidin-based affinity enrichment experi-
ments from miniTurbo-FLYWCH1 cells revealed numerous
FLYWCH1 proximal proteins (Fig. 3f and Supplementary Fig. 3k).
These FLYWCH1-proximal proteins include the H3K9me3 methyl-
transferase EHMT1, the HP1 interactor MGA, subunits of the
chromosomal passenger complex (INCENP, CDCA8), and Poly-
comb proteins. In summary, these experiments uncovered
FLYWCH1 as an H3K9me3 proximal protein that localizes to a
subset of (peri)centromeres in human cells, together with many
additional H3K9me3-associated proteins. Future experiments using
FLYWCH1 perturbations experiments are needed to further uncover
a putative role for FLYWCH1 in centromere maintenance or
regulation and cellular homeostasis.
Discussion
In this study, we present an enzyme, called ProtA-Turbo, which
can be used for proximity biotinylation and interaction pro-
teomics purposes without the requirement for genetic manipula-
tion or transfection of target cells. We illustrate the applicability of
the ProtA-Turbo enzyme by targeting three nuclear baits using
polyclonal antibodies and we show that the enzyme can be used
for interaction proteomics studies using fixed and non-fixed cells.
Finally, we illustrate the usefulness of the ProtA-Turbo enzyme
through the identification and initial characterization of a rela-
tively uncharacterized protein, FLYWCH1, as a marker of cen-
tromeric, H3K9me3-marked chromatin.
Over the years, a range of methods has been developed to
determine the proximal proteome of a protein of interest. ChIP-
MS-based approaches (i.e. antibody-based enrichment of chro-
matin fragments) are solely applicable to chromatin-bound pro-
teins, require sonication, which is a highly variable process16, and
take several days to perform, thus limiting throughput8. Proxi-
mity biotinylation requires transfection or genetic manipulation,
which potentially induces biological changes in the cell type of
interest. Furthermore, genetic manipulation of target cells is
labor-intensive and is not applicable to all types of cells, such as
non-proliferative primary cells. As an alternative, antibody-HRP
(horseradish peroxidase) conjugates can be used to biotinylate
local environments, but these methods are restricted to fixed
material since HRP is denatured in the acidic environment of live
cells17,18. The fixed version of the off-the-shelf method presented
here extends on the principle of the antibody-HRP conjugates,
achieves higher enrichment of target-site specific GO terms, and
is less labor-intensive (cf. BAR, Fig. S1j). Both HRP and ProtA-
Turbo-based methods rely on the specificity of the used anti-
bodies as well as the abundance of the proteins or modifications
that are targeted. ProtA-Turbo-targeting experiments on low
abundant proteins or modifications may suffer from high back-
ground biotinylation signal since at any given time a number of
ProtA-Turbo molecules may not be target engaged. ‘Classical’
proximity biotinylation experiments in which the bait of interest
is directly fused to a biotinylation enzyme do not suffer from
these drawbacks. On the other hand, fusing a proximity bioti-
nylation enzyme to a bait protein of interest may negatively affect
the function of that bait. Furthermore, PTMs are difficult to target
using classical proximity biotinylation experiments but these can
easily be targeted using the ProtA-Turbo enzyme. Thus, classical
proximity biotinylation experiments and ProtA-Turbo mediated
proximity biotinylation experiments each have their own pros
and cons and are complementary in nature.
While off-the-shelf proximity biotinylation on cross-linked
cells enriches the local proteome of a protein of interest, the usage
of formaldehyde-based crosslinking precludes certain down-
stream applications. A notable example comprises crosslinking-
mass spec (XL-MS), which can be used to discriminate directly
from indirect protein–protein interactions19. This approach
almost exclusively targets unmodified lysine residues20, but for-
maldehyde fixation of cells also targets these lysines. To allow
future studies aimed at combining XL-MS with proximity bioti-
nylation, omission of crosslinking would be beneficial. The native
off-the-shelf workflow developed in the current study thus allows
additional downstream workflows, including assessing
protein–protein interaction topologies using XL-MS. In addition,
we noticed that some cell types, such as U937 cells, tend to clump
after crosslinking, resulting in loss of material. The native
workflow circumvented these issues and allowed to obtain of a
comprehensive H3K9me3 proximal proteome in U937 cells.
Another advantage of the native version is that it is less labor-
intense compared to the fixed protocol. The crosslinking-based
and native workflows yield comparable results. However, we do
observe some technical variability between experiments con-
cerning, for example, fold enrichments for bait-proximal proteins.
We believe these variations are technical in nature related to for
example small differences in washing conditions and generated
lysates. Use of the cross-linking-based versus the native method
will depend on potential downstream applications and target cells
of interest. Both approaches enrich a range of expected proteins
from targeted subcellular compartments. However, it is con-
ceivable that fixation and/or permeabilization may have mild
effects on protein complex formation or localization. Therefore,
orthogonal methods (such as western blotting, immuno-
fluorescence, or ChIP-seq) should be applied to validate newly
identified proximal proteins for baits of interest. Finally, affinity
purifications from crude lysates using commonly used affinity
enrichment reagents such as Flag, HA, and streptavidin beads
suffer from false-positive contaminants, which are reported in the
so-called CRAPome repository21. The streptavidin-based affinity
enrichments we performed in this study also yielded a number of
proteins that are listed in the CRAPome repository as potential
false positive hits (also see Source Data). These issues might be
partially overcome by mapping biotinylated peptides in bait
proximal proteins, as reported previously22–24. However, in the
experimental workflow used here with partial tryptic digestion on
beads followed by further digestion in the solution overnight,
biotinylated peptides remain bound to streptavidin beads
(streptavidin bound to the beads does not get completely digested
during a brief trypsin incubation at RT), while other tryptic
peptides are released from the beads, preventing identification of
biotinylated peptides in the mass spectrometer.
In the current study, we focused on targeting the ProtA-Turbo
enzyme to nuclear proteins and a transcriptionally repressive
histone modification. Future applications of the ProtA-Turbo
enzyme will include targeting cytoplasmic and cell-surface pro-
teins, for example in the context of cancer immunotherapy.
Furthermore, modifications on nucleic acids such as DNA or
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RNA methylation can be targeted using commercially available
high-quality antibodies against these modifications. Other options
include fusing TurboID to specific chromatin reader domains to
generate an off-the-shelf alternative to the recently developed
ChromID technology11. Together, these off-the-shelf approaches
provide a highly flexible toolbox to perform proximity biotiny-
lation assays in any cell type of interest in a fast and efficient
manner.
Methods
Cell culture. HeLa (source: ATCC) and MCF7 (source: ATCC) cells were cultured
in Dulbecco’s modified Eagle medium (DMEM, Gibco) supplemented with 10%
FBS and penicillin/streptomycin. U397 cells (source: ATCC) were cultured in
RPMI with 10% FBS and penicillin/streptomycin. Low passage primary fibroblasts
from Coriell institute (AG08469) were cultured with DMEM supplemented with
15% FBS and penicillin/streptomycin and used until passage 12. Mouse ESCs
Suv39h1/2 WT and double KO were a kind gift from Dr. Thomas Jenuwein and
were cultured in DMEM supplemented with 15% FBS, penicillin/streptomycin,
10 mM sodium pyruvate, 5 μM beta-mercaptoethanol, and leukemia inhibitory
factor (1000 U/ml).
Primers and oligonucleotides. A full list of primers and oligonucleotides used in
this work is found in Supplementary Table 1.
Recombinant protein purification. The MNase sequence in the pk19pAMNase
vector (pk19pAMNase was a gift from Ulrich Laemmli25, Addgene #86973) was
substituted by the TurboID sequence. TurboID was amplified from the plasmid
3xHA TurboID NLS pcDNA3 (3xHA TurboID NLS pcDNA3 was a gift from Alice
Ting7, Addgene #107171) and inserted in the pK19 vector between EcoRI and
BamHI restriction enzymes using the primers TurboEcoRI-F, TurboBamHIfrag-R,
TurboBamHIfrag-F, and TurboBamHI-R. A histidine stretch was added later to the
N-terminal part of the protein using the oligos 6xHistagHinDIII-F and
6xHistagHinDIII-R to facilitate purification of the enzyme.
The Pk19 ProtA-Turbo plasmid was transformed into C3013 E. coli. Colonies
were grown overnight and cultured in 2 l LB medium until reaching OD 0.6.
Protein expression was then induced for 3 h with 2 mM IPTG. The bacteria were
harvested, resuspended in 70 ml of lysis buffer (0.5 M NaCl, 10% glycerol, 20 mM
HEPES pH= 8, 1 mM EDTA pH= 8, 0.1% NP40, 20 mM b-mercaptoethanol, and
1 mM PMSF) and sonicated. The lysate was centrifuged for one hour at 12,000 × g
at 4 °C to eliminate debris. The protein extract was then allowed to pass through a
column (Econo-Pack Disposable Chromatography Columns, 10 ml, BioRad)
containing 2 ml Ni-NTA agarose beads (Qiagen) by gravity flow, and the column
was then washed once with lysis buffer and twice with wash buffer (10 mM Tris,
0.5 M EDTA, 10% Glycerol, 500 mM NaCl). A pre-elution was performed with
5 ml of wash buffer containing 15 mM Imidazol and 1 ml fractions were collected.
The majority of the ProtA-Turbo enzyme was then eluted with 10 ml of wash
buffer containing 100 mM Imidazol, also collected in 1 ml fractions. Aliquots of the
collected fractions were loaded on an SDS–PAGE gel and stained with Imperial
Protein Staining (Thermo Scientific) following the manufacturer’s instructions to
determine the amount and purity of the enzyme. Fractions were pooled according
to their similarity on gel and were snap-frozen and stored at −80 °C until
further usage.
ProtA-Turbo immunofluorescence. Cells were cultured in coverslips (15 mm
diameter) in a 12-well plate. The next day, cells were washed with PBS and, after
that, fixed in PBS containing 4% v/v PFA for 15 min at RT, washed three times with
PBS, permeabilized in PBS containing 0.3% v/v Triton for 10 min, and blocked in
blocking solution (3% BSA in 0.3% Triton-PBS) for 30 min. Coverslips were then
incubated for one hour in a humid chamber with primary antibody diluted 1:150 in
blocking solution (H3K9me3 antibody (Abcam, ab8898), BRG1 antibody (A300-
813A, Bethyl), and Emerin antibody (10351-1-AP, Proteintech)). Coverslips were
washed four times with PBS and incubated with 140 ng of ProtA-Turbo enzyme
diluted in 30 μl of blocking buffer per coverslip for one hour and then washed 4
times with PBS. Coverslips were then incubated with biotin reaction buffer (5 mM
MgCl2, 5 μM Biotin, 1 mM ATP in PBS) for 10 min at 37 °C, followed by three
washes with PBS. Finally, coverslips were incubated with secondary antibody (anti-
rabbit Alexa fluor 568 (Life Technologies A11004, dilution 1:1000), FITC-Avidin
(ThermoFisher Scientific A821, 1:200) and DAPI for one hour, washed 4 times
with PBS and fluoromount G (Thermo, 00-4958-02) was used for mounting the
slides. Images were acquired with a confocal microscope LSM900 (ZEISS) and
analyzed with Fiji software.
Prot A-Turbo targeting in fixed cells. Cells were cultured in 15 cm dishes. Next
day, cells were washed once with PBS and then fixed in 3 ml of PBS containing 4%
v/v PFA for 15 min at RT. Cells were then collected using a cell scraper. After
fixation cells were centrifuged at 150 × g for 3 min at RT. At least 70 μl of cell pellet
was used for each antibody. Cell pellet was resuspended in 1 ml of hypotonic lysis
buffer (10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.3% NP40, and 10%
glycerol), incubated for 10 min on ice, and then centrifuged at 800 × g for 8 min at
4 °C to isolate the nuclei. Nuclei were then washed three times with 0.5 ml of
hypotonic lysis buffer and centrifuged at 200 × g for 2 min at 4 °C. Nuclei were then
washed once with 0.5 ml of PBS. From this step, centrifugations were performed at
RT between 100 and 900 × g (required centrifugation speed to pellet cells varies
depending on the cell type) for 3 min. Nuclei were resuspended and permeabilized
in 1 ml of PBS supplemented with 0.3% v/v Triton-X100 and incubated in a
rotation wheel for 10 min. Non-specific-binding sites were blocked with 1 ml PBS
containing 0.3% Triton-X100 supplemented with 3% BSA for 30 min in a rotation
wheel at RT. Samples were then incubated with 3 μg of primary antibody diluted in
300 μl of blocking solution (IgG rabbit antibody (12-370, EMD Millipore),
H3K9me3 antibody (Abcam, ab8898), BRG1 antibody (A300-813A, Bethyl), and
Emerin antibody (10351-1-AP, Proteintech)) in a rotation wheel for one hour at
RT. To remove the unbound antibody, nuclei were washed twice with 500 μl of
PBS. Next, nuclei were incubated with 3.4 μg of ProtA-Turbo enzyme diluted in
300 μl blocking solution for one hour in a rotation wheel at RT. The unbound
ProtA-Turbo was then removed by washing the pellet twice with 500 μl of PBS.
Next, samples were incubated with 300 μl of biotin reaction buffer (5 mM MgCl2,
5 μM Biotin, 1 mM ATP in PBS) in a thermo shaker at 1000 rpm for 10 min at
37 °C. Samples were then centrifuged, washed once with 1 ml PBS and finally lysed
in 300 μl of RIPA buffer (50 Mm Tris pH 7.8, 150 mM NaCl, 0.5% sodium
deoxycholate, 0.1% SDS, 1% NP40). overnight on ice.
The following day, samples were sonicated using a Bioruptor sonicator
(Diagenode) (6–10 cycles of 30 s ON 30 s off, maximum power) until the samples
became more transparent and then decrosslinked for one hour at 95 °C after
addition of SDS to a final concentration of 1%. After an additional sonication cycle,
samples were centrifuged at 21,000 × g for 10 min at 4 °C. Supernatant was then
recovered and incubated with 12.5 μl streptavidin sepharose high-performance
beads (15511301, Cytiva) on a rotation wheel for 2 h at 4 °C. Beads were then
washed 5 times with 0.5 ml RIPA buffer. At this point in the protocol, if the
purpose was to perform a Western Blot, 40 μl of protein loading buffer (125 mM
Tris pH 6.8, 25% glycerol, 5% SDS, 0.1% bromophenol blue, 1.43M b-
mercatoethanol) was added to the beads after which they were boiled at 95 °C for
10 min. Samples were then loaded on an SDS–PAGE gel and further processed for
western blotting. If the purpose was to analyze samples by mass spectrometry, the
experiments were performed in triplicate for each antibody and, after 5 washes with
500 μl of RIPA buffer, the beads were washed 4 times with 500 μl of PBS. 50 μl of
elution buffer (2M Urea, 10 mM DTT, 100 mM Tris pH 8) was then added to the
beads, followed by incubation on a thermo shaker at 1500 rpm for 20 min at RT.
Iodoacetamide was then added to the samples to a final concentration of 50 mM
and samples were incubated in a thermo shaker at 1500 rpm in the dark for 10 min
at RT. 2.5 μl of trypsin (0.1 mg/ml trypsin stock solution) was then added to each
sample, followed by incubation in a thermo shaker at 1500 rpm for 2 h at RT.
Samples were then centrifuged and the eluates were collected. 50 μl of elution
buffer was then added to the beads and after incubation in a thermo shaker at
1500 rpm for 5 min at RT, the eluates were collected and combined with the first
elution fraction. 1 μl of fresh trypsin was then added to each sample and samples
were incubated overnight at RT. The following day, peptides were acidified by
adding 10 μl of 10% v/v TFA and purified on C18 Stagetips (3M Empore)26.
Peptides on Stagetips were stored at 4 °C until being subjected to LC–MS.
When H3K9me3 (Abcam, ab8898) or Emerin antibody (10351-1-AP,
Proteintech) was used, isolation of nuclei was performed before fixation. Briefly,
cells were washed with PBS, collected and transferred to an Eppendorf. Cells were
centrifuged at 400 × g for 3 min at RT after which the supernatant was removed.
Cell pellet was then resuspended in 1 ml of hypotonic lysis buffer (10 mM Tris pH
7.5, 10 mM NaCl, 3 mM MgCl2, 0.3% NP40, and 10% glycerol), incubated on ice
for 10 min, and then centrifuged at 800 × g for 8 min at 4 °C. Nuclei were then
washed three more times with 500 μl of lysis buffer and once with PBS followed by
centrifugation at 200 × g for 2 min at 4 °C. Nuclei were then fixed in 1 ml of PBS
containing 4% v/v PFA and incubated in a rotation wheel for 15 min at RT. Finally,
nuclei were washed twice with PBS and permeabilized with 1 ml of PBS containing
0.3% v/v Triton-X100 and incubated for 10 min in a rotation wheel at RT. From
this step, samples were processed as described for the other antibodies.
ProtA-Turbo targeting in unfixed cells. Cells were washed with PBS and col-
lected from the plates using a cell scraper. Then, cells were centrifuged at 150 g for
3 min at RT. Around 70 μl of cell pellet was used for each replicate. Cell pellets were
incubated with 500 μl of digitonin buffer (0.04% digitonin diluted in 20 mM
HEPES KOH pH 7.5, 150 mM NaCl, 0.5 mM Spermidine) in a rotation wheel for
10 min at RT. A small aliquot of sample was then stained with trypan blue and
analyzed using a Countess Cell Counter (Invitrogen) for cell viability. Samples were
further processed when cell viability was <20%, thus ensuring sufficient outer
membrane permeabilization. If cell viability was >20%, more digitonin buffer or a
higher digitonin concentration was added to obtain >80% non-viable cells. Next,
cells were centrifuged at 100–900 × g (required centrifugation speed to pellet cells
varies depending on the cell type) for 3 min at RT. 2 μg of antibody (IgG, Emerin,
BRG1, and H3K9me3) diluted in 200 μl digitonin buffer was then added to the
samples. Samples with antibodies were incubated for 20 min in a thermo shaker at
600 rpm at RT. Cells were then washed twice with digitonin buffer and incubated
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with 1.4 μg of ProtA-Turbo enzyme diluted in 500 μl digitonin buffer in a rotation
wheel for 30 min at 4 °C. Cells were then washed twice with digitonin buffer. Next,
cells were incubated with biotin reaction buffer (5 mM MgCl2, 5 μM Biotin, 1 mM
ATP in digitonin buffer) in a thermo shaker at 1000 rpm for 10 min at 37 °C. Cells
were washed once with 0.5 ml wash buffer without digitonin, resuspended in 300 μl
RIPA buffer (50 Mm Tris pH 7.8, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1%
SDS, 1% NP40), and incubated overnight on ice. The following day, the samples
were sonicated in an NGS Bioruptor (Diagenode) until the samples appeared
transparent. Samples were then centrifuged at 21,000 × g for 10 min at 4 °C after
which the supernatant was incubated with 12.5 μl Streptavidin Sepharose High-
Performance beads (15511301, Cytiva). From this step onwards, the procedure is
the same as described for the protocol with fixed cells.
When the H3K9me3 or Emerin antibodies were used in HeLa cells, nuclei were
isolated before antibody incubation. Briefly, cells were washed with PBS, collected
using a cell scraper, and transferred to an Eppendorf. After centrifugation at
100 × g for 3 min, the cell pellet was resuspended in 1 ml of hypotonic lysis buffer
(10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.3% NP40, and 10% glycerol),
incubated for 10 min on ice and then centrifuged at 800 × g for 8 min at 4 °C.
Nuclei were then washed three times with the same buffer and centrifuged at
200 × g for 2 min at 4 °C. Finally, cells were washed once with wash buffer (no
digitonin) and incubated with 2 μg antibody diluted 200 μl digitonin buffer. From
this step samples were processed as described for the other antibodies.
LC–MS/MS measurements. Digested peptides were eluted from C18 Stagetips
with 30 μl of buffer B (0.1% formic acid, 80% acetonitrile) and after speedvac
centrifugation to 5 μl, buffer A (0.1% formic acid) was added to a total volume of
12 μl. 6 μl of each sample was then loaded on an Easy-nLC1000 (Thermo) con-
nected online either an LTQ-Orbitrap-Fusion (Thermo), an LTQ-Orbitrap Q-
Exactive HFX mass spectrometer (Thermo) or an Orbitrap Exploris (Thermo). The
LC–MS and data acquisition method used for the LTQ-Orbitrap-Fusion were: a
gradient from 9% to 32% buffer B for 114 min before washes at 50% then 95%
buffer B were performed, for 140 min of total data-collection time. Scans were
collected in data-dependent top speed mode with dynamic exclusion set at 60 s. For
the LTQ-Orbitrip Q-Exactive, peptides were separated with a 94-min gradient from
9% to 32% buffer B followed by washes at 50% and then 95% buffer B for 120 min
of total data-collection time. All scans were collected in data-dependent mode and
collected in a top10 data-dependent acquisition mode27–29. For the Orbitrap
Exploris, an acetonitrile gradient of 12–30% in 43 min was used, after which the
acetonitrile concentration was increased to 60% in 10 min and then up to 95% in
1 min. Total data acquisition time was 60 min. The spray voltage was set to 2200 V
in positive ion mode. The expected LC peak width was 15 s. The full scan of the
peptides was set to a resolution of 120,000 in a scan range of 350–1300m/z. The
normalized AGC target was 300% and the maximum injection time was set to
20 ms.
LC-MS/MS data analyses. Raw files were analyzed using standard settings of
MaxQuant 1.5.1.0. Options LFQ, iBAQ, and match between runs were enabled. As
a search database, the human fasta database updated in 2017 from Uniprot was
used. Perseus 1.5.0.15 was used to filter proteins flagged as a contaminant, reverse
or only identified by site. All of the experiments were performed in triplicate for
each antibody, using an independent cell mixture for each replicate as input. The
triplicates were grouped based on experimental conditions (based on the primary
antibody used) and only proteins that had an LFQ value in each of the replicates in
at least one group of triplicates were maintained for downstream analyses. Next,
missing values were imputed using default parameters in Perseus. Statistically
different proteins were identified using a Student’s t-test (FDR < 0.05) between
targeted bait triplicates and IgG control triplicates. Additionally, a protein was
called enriched only when it also had at least a 1.5-fold change over the IgG
controls. The volcano plots were generated by plotting the −log10 of the p-value,
calculated by a Student’s t-test comparing the bait-triplicates with IgG triplicates,
against the fold change (which corresponds to the average fold change between
bait-triplicates and IgG triplicates). Downstream data visualization was performed
in R. Proteins that are known to localize to H3K9me3 domains, nuclear lamina, or
SWI/SNF complexes were determined using literature curation. Pericentric het-
erochromatin binding proteins were obtained from pericentromeric purifications
in mouse ESCs30. GO-analyses were performed using Clusterprofiler v4.0.031. For
GO-based comparison of ProtA-Turbo Emerin with other published lamin-
targeting strategies, we used data for nuclear lamina microdomain mapping
(LAP2B-BioID32), a two-component lamina BioID mapping strategy (2C-BioID33),
conventional Lamin A BioID3, and an antibody-HRP-based method for biotiny-
lation by antibody recognition (BAR17). Enriched proteins were defined according
to the following criteria: LAP2B-BioID > 1.5-FC/ctrl; 2C-BioID > 1.5-FC/ctrl
(-noAP21967); Lamin A BioID: proteins were downloaded from Table S1; BAR: all
proteins of the LMNA Unbound sample that are >2 fold enriched over control,
were not shared with the no antibody control and had at least 2 unique peptides.
All GO terms were determined using Clusterprofiler and 10 GO terms centered
around the nuclear lamina were selected for evaluation of method performance.
For the interaction network, proteins were selected that were significantly enriched
in either H3K9me3 enrichments (HeLa fixed, HeLa unfixed, MCF7 fixed, and U937
unfixed) and showed at least a two-fold enrichment over IgG control. Proteins
present in at least three of these datasets were retained and queried using the
stringapp plugin of Cytoscape 3.8.234. Disconnected nodes, and nodes that had no
interaction as determined using experimental evidence or documented in a data-
base, were removed. All proteins that were enriched in either of the fixed or unfixed
ProtA-Turbo experiments were searched in the Crapome database21 against all
proximity biotinylation experiments performed on human cells. Proteins that are
both enriched in ProtA-Turbo experiments with different baits relative to IgG
(indicating potential non-specific enrichment), and that are frequently found in the
Crapome database with a relatively high average spectral count, are more likely to
be contaminant proteins than those with specific enrichment for one bait and a low
frequency and low average spectral counts in the Crapome database (see also
Source Data).
ChIP-sequencing. Cells were crosslinked with 1% formaldehyde for 10 min at RT
and then quenched with 125 mM glycine for at least 5 min at RT. Cells were
washed with PBS, collected using a cell scraper, and pelleted. Cell pellets were
resuspended in 5 ml buffer B (0.25% TritonX-100, 10 mM EDTA, 0.5 mM EGTA,
and 20 mM HEPES) per 15 cm dish, collected, and centrifuged at 1000 × g for
5 min at 4 °C. The resulting pellet was incubated with 30 ml of buffer C (150 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, and 50 mM HEPES) in a rotation wheel for
10 min at 4 °C and centrifuged again at 1000 × g for 5 min at 4 °C. The resulting
pellet consisted of isolated nuclei. The nuclei were resuspended in 1 ml of incu-
bation buffer (0.15% SDS, 1% Triton, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA
and 20 mM HEPES) and sonicated in a Bioruptor Pico sonicator (Diagenode).
Chromatin fragment size was checked by decrosslinking 5 μl of sample and run-
ning this on an agarose gel. Most chromatin fragments were around 300 bp. 300 μl
of chromatin was incubated with 3 μl of V5 antibody (P/N 46-0705, Invitrogen) in
a rotation wheel overnight at 4 °C, together with a mix of 7.5 μl of protein A
Dynabeads (10008D, Invitrogen) and 7.5 μl protein G Dinabeads (10009D, Invi-
trogen). Beads were then washed twice with Buffer 1 (0.1% SDS, 0.1% NaDOC, 1%
TritonX-100, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA and 20mM HEPES),
once with Buffer 2 (0.1% SDS, 0.1% Na doxycholate, 1% TritonX-100, 500 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA and 20mM HEPES), once with buffer 3 (0.5%
NaDOC, 0.5% NP40, 250 mM LiCl, 1 mM EDTA, 0.5 mM EGTA and 20 mM
HEPES) and twice with buffer 4 (1 mM EDTA, 0.5 mM EGTA, 20 mM HEPES).
For every wash, the beads were incubated with washing buffer in a rotation wheel
for 5 min at 4 °C. After the washes, chromatin was eluted by adding 200 μl of
elution buffer to the beads (1% SDS and 0.5 mM NaHCO3) followed by incubation
in a rotation wheel for 20 min at RT. The supernatant containing the eluted
chromatin was decrosslinked by adding 8 μl of 5 M NaCl and 2 μl of 10 mg/ml
Proteinase K and incubation in a thermo shaker at 1000 rpm for at least 4 h at
65 °C. DNA was purified using MiniElute columns (Qiagen). The library for
sequencing was prepared with a Kapa HyperPrep Kit (Kapa Biosystems) following
the manufacturer’s instructions. NEXTflex adapters (Bio Scientific) were used
during the sample prep. Samples were analyzed on an Agilent 2100 Bioanalyzer for
purity and sequenced on an Illumina NextSeq500.
ProtA-Turbo ChIP-sequencing for H3K9me3. Cells were first subjected to the
ProtA-Turbo protocol described for fixed cells using the H3K9me3 antibody. After
washing away the biotinylation reaction buffer, nuclei were resuspended in 1 ml of
SDS buffer (50 mM Tris pH 8, 0.5% SDS, 100 mM NaCl, 5 mM EDTA) and
incubated for 10 min on ice. Nuclei were then pelleted and resuspended in 300 μl of
IP buffer (0.3% SDS, 1.1% Triton, 1.2 mM EDTA, 16.7 mM Tris pH 8, 167 mM
NaCl) and sonicated in a Bioruptor Pico Sonicator. The samples were precleared
with 30 μl Dynabeads protein A and 5 μl of 5% v/v BSA (final concentration
~0.05%) in a rotation wheel for 1 h at RT. Next, samples were incubated with 30 μl
of Streptavidin M280 beads (Invitrogen) for 3 h at RT. Beads were then washed
twice with 2% SDS and three times with LiCl buffer (100 mM Tris pH 8, 500 mM
LiCl, 1% NP40, 1% sodium deoxycholate). Samples were then incubated in 60 μl of
300 mM NaCl in a thermo shaker at 1000 rpm overnight at 65 °C. Following day,
15 μl of proteinase K buffer (50 mM Tris pH 7.5, 25 mM EDTA, 1.25% SDS) and
1.5 μl proteinase K (10 mg/ml) was added to the sample followed by incubation in a
thermo shaker for 2 h at 45 °C to ensure complete decrosslinking. The supernatant
was then collected. DNA was purified using MiniElute columns (Qiagen). Library
preparation for sequencing was performed as described for FLYWCH1 ChIP-
sequencing.
ChIP-sequencing analysis. ChIP-seq libraries were sequenced paired-end on an
Illumina Nextseq 500 sequencer. For biotin ChIP-seq after ProtA-Turbo targeting
using H3K9me3 antibody or IgG control, the reads were mapped against the hg38
genome build using bwa 0.7.17 with parameters mem -t 3235. Reference H3K9me3
ChIP-seq in wild-type HeLa cells was downloaded from GEO (accession number
GSE8681436) and processed in parallel. Duplicate reads were identified and filtered
using Picard tools version 1.129 (http://broadinstitute.github.io/picard/).
FLYWCH1 and IgG ChIP-seq were processed using the seq2science pipeline37.
Parameters were fastp as trimmer, bwa-mem2 as aligners, minimal map quality of
30. For all files, peaks were called using macs2 2.2.7.138 with q-value 0.001 for
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H3K9me3 tracks and q 0.05 for FLYWCH1 and IgG ChIP-seq. Bigwig files were
visualized in the Integrative Genomics Viewer39. ChIP-seq heatmaps were gener-
ated using fluff 3.0.340. Motif analysis was performed using Homer v4.1141 using
default parameters, genome hg38, and width 200. Karyotype plots were generated
in R using karyoploteR 1.18.042. For intersection with repeat elements, the repeat
masker database was downloaded using the UCSC table browser. Reads inter-
secting the repeat coordinates were obtained using tools 2.27.1 multicov. Only
repeat regions that had more than 1000 reads and were at least 10-fold different
between FLYWCH1 and IgG ChIP-seq were retained.
Immunofluorescence. Immunofluorescence was performed using the same pro-
tocol as described for the ProtA-Turbo protocol with the omission of protA-Turbo
addition and biotinylation. The following primary antibodies were used: α-
H3K9me3 (Abcam, ab8898 and Active Motif, 61014), α-FLYWCH1 (Novus Bio-
logicals, NBP1-85041), α-FLAG (Sigma, F3165), and α-INCENP (Active Motif,
39260) all in a 1:150 dilution.
FLYWCH1, RNF169, SENP1, and SENP7 overexpression. EGFP FLYWCH1 was
cloned in the pEGFP-C3 vector. FLYWCH1 cDNA was amplified using as a
template the vector IRATp970F08101D from Source Bioscience with the primers
FLYWCH1EcorI-Fw and FLYWCH1KpnI-Rv. Both vector and PCR products were
cut by EcoRI and KpnI and ligate. FLAG-RNF169, FLAG SENP1, and FLAG-
SENP7 was overexpressed using the plasmid pcDNA5-FRT/TO-Flag-RNF169 (this
plasmid was a gift from Daniel Durocher43, Addgene plasmid # 74243), the plas-
mid Flag-SENP1 (this plasmid was a gift from Edward Yeh44, Addgene plasmid #
17357), and plasmid Flag-SENP7 (a gift from Edward Yeh45, Addgene plasmid #
42886), respectively. HeLa cells were transfected with PEI and harvested 48 h after
transfection or fixed for immunofluorescence analyses.
Knock-in cell lines. The pUC57 modified plasmid (a kind gift from Jop Kind lab)
and the pU6-(BbsI)-Cbh-Cas9-T2A-mCherry (pU6-(BbsI)-Cbh-Cas9-T2A-mCherry
plasmid (a gift from Ralf Kuehn46, Addgene #64324) were used for tagging endo-
genous FLYWCH1 and Emerin. For FLYWCH1, the gRNA (GGGTGCTGAGCGTG
GCCTGA) was inserted in the pU6-(BbsI)-Cbh-Cas9-T2A-mCherry and it targets the
5′ end of the FLYWCH1 sequence. FLYWCH1 homology arms were inserted in both
sites of BSD-P2A-GFP-V5 or BSD-P2A-MiniturboID-V5. The gBlock HA1FLYW
CH1 was inserted as a homology arm in the vector and the primers HA2FLYWCH1
NotI-Fw and HA2FLYWCH1NotI-Rv were used for the amplification of one of the
homology arms from cDNA. The primers TurboNheIfrag-F, TurboNheIfrag-R,
TurboNotI-R, and MiniTurbogoodNheI-F were used to amplify MiniturboID from
the vector 3xHA MiniTurboID NLS pcDNA3 (3xHA miniTurboID NLS pcDNA3
was a gift from Alice Ting7, Addgene #107172) and replace GFP and the gBlock 3xV5
to add V5 and a flexible linker as a tag. For Emerin, the gRNA (CGCCCACGCCCG
AGTCCGCC) was also inserted in the same vector as for FLYWCH1. Then, Emerin
homology arms were inserted in both sites of BSD-P2A-Turbo. Homology arms were
amplified from cDNA using the primers HA1emerinMluI-Fw, HA1emerinNcoI-Rv,
HA2emerinHindIII-Fw, and HA2emerinAscI-Rv. For both FLYWCH1 and Emerin,
the length used for the homology arms was ~500 bp upstream and downstream from
the start transcription site. The two homology arm vectors were transfected as a ratio
1:1 in HeLa cells and then the tagged cells were selected with blasticidin.
Protein extract and streptavidin pulldown of Turbo and miniturbo-tagged cell
lines. WT and tagged cells were treated with 50 mM biotin (B20656, Life tech-
nologies) in a culture medium for one hour at 37 °C. The cells were washed with
PBS and collected by scraping. Cells were then pelleted and nuclei were isolated
using Nuclear Isolation Buffer (15 mM Tris pH 7.5, 15 mM NaCl, 60 mM KCl,
5 mM MgCl2, 1 mM CaCl2, 250 mM Sucrose and 0.03% NP40). Cells were incu-
bated in this buffer for 30 min in a rotation wheel at 4 °C and then centrifuged at
3200 × g for 10 min at 4 °C. Isolated nuclei were resuspended in RIPA buffer and
sonicated in a Bioruptor until the extract was almost transparent. Samples were
then centrifuged at maximum speed for 10 min at 4 °C to eliminate debris. The
supernatant was collected and protein concentration was measured using Bradford
assay. Approximately 4 mg of protein per reaction was incubated with 12.5 μl
Streptavidin Sepharose High-Performance beads (15511301, Cytiva) and 50 μg/ml
(final concentration) of Ethidium bromide (Sigma) for 2 h in a rotation wheel at
4 °C. Finally, samples were processed for LC–MS analyses using the same proce-
dure as described for the ProtA-Turbo protocols.
Western blotting. Samples were incubated in an SDS loading buffer for 5 min at
95 °C after which proteins were separated on an SDS–PAGE gel. Proteins were
transferred from the gel to a nitrocellulose membrane using a Trans-Blot Turbo
Transfer System (Bio-Rad) according to the manufacturer’s instructions. Mem-
branes were blocked in blocking solution (5% milk in 0.1% Tween-PBS or 5% BSA
in 0.1% Tween-PBS for the membranes that were used to stain biotin) in a shaker
for 30 min at RT. Membranes were incubated in a shaker overnight at 4 °C with the
antibody diluted in blocking solution, apart from V5 antibody, which was incu-
bated in PBS+ 0.1% v/v Tween. The antibodies used in this study were α-actin
(A1978, SIGMA) diluted 1:5000, α-BRG1 (Bethyl, A300-813A) diluted 1:1000, α-
H3K9me3 (Abcam, ab8898) diluted 1:1000, α-emerin (10351-1-AP, Proteintech)
diluted 1:1000, α-V5 antibody (P/N 46-0705, Invitrogen) diluted 1:1000, α-FLAG
(Sigma, F3165) diluted 1:1000, α-SENP1 (Novus Biologicals, NBP2-55420) diluted
1:1000, α-SENP7 (Bethyl laboratories, A302-995A-T) diluted 1:1000 and α-HP1α
(Cell Signaling, 2616S) diluted 1:1000. Next, membranes were incubated with HRP
secondary antibody (Polyclonal Rabbit anti-Mouse Immunoglobulins/HRP P0260
or Polyclonal Swine anti-Rabbit Immunoglobulins/HRP P0399, both of them from
Agilent Dako) diluted 1:1000 in PBS with 0.1% v/v Tween. Membranes blotted for
biotin were incubated with HRP-Streptavidin (5911, Invitrogen) diluted 1:1000 in
blocking solution with BSA for 1 h at room temperature. All of the membranes
were developed using Supersignal West Pico Plus Chemiluminescent Substrate
reagent (34580, Thermo Scientific) and imaged using ImageQuant LAS4000.
Nuclear protein extraction. Cells were resuspended in the hypotonic Buffer A
(10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.1% NP40, 0.5 mM DTT),
incubated 10 min on ice and centrifuged at 400 × g for 5 min at 4 °C. The pellet was
resuspended again with Buffer A containing 0.15% v/v NP40 and transferred to a
dounce homogenizer (type B pestle) to mechanically break the cytoplasmic
membranes. The sample was then centrifuged at 3200 × g for 15 min at 4 °C. The
nuclear pellet was washed with PBS once without resuspending the nuclei. Then,
nuclei were incubated with Buffer C (420 mM NaCl, 20 mM HEPES pH 7.9, 20%
glycerol, 2 mM MgCl2, 0.2 mM EDTA, 0.1% NP40, 0.5 mM DTT) in a rotation
wheel for 1 h at 4 °C and centrifuged at 21,000 × g for 30 min at 4 °C. The super-
natant represents the nuclear extract47,48.
Peptide pulldown. The peptides used in this experiment contain the first 17 amino
acids from histone H3 with or without trimethylation on lysine 9 (H3K9me3)
followed by two glycines and a biotinylated lysine and they were synthesized using
the Fmoc strategy49,50. Peptides were dissolved in Buffer A (150 mM NaCl, 50 mM
Tris pH 8, 0.1% NP40) and incubated with 75 μl of Dynabeads MyOne Streptavidin
C1 (Invitrogen, 65001) previously equilibrated with Buffer A. Beads were then
washed twice with Buffer A and incubated with 500 μg nuclear extract diluted in
dilution buffer (150 mM NaCl, 50 mM Tris pH 8, 2% NP40, 0.5 mM DTT, 10 μM
ZnCl2) in a rotation wheel for 3 h at 4 °C. After incubation, beads were washed
three times with 1 ml dilution buffer containing 350 mM NaCl and twice with 1 ml
dilution buffer. 40 μl of SDS loading protein buffer was then added to the beads
after which samples were incubated for 5 min at 95 °C and loaded on an
SDS–PAGE gel for western blot analyses.
DNA pulldown. The sequences of the oligonucleotides used for the DNA affinity
purifications can be found in Supplementary Table 1. Oligos were annealed in
Annealing buffer (20 mM Tris pH 8, 100 mM NaCl, 2 mM EDTA, forward oligo
20 μM, reverse oligo 30 μM) by heating the mixture at 95 °C for 10 min and then
cooling it down to RT slowly. 20 μl Streptavidin Sepharose High-Performance
beads (15511301, Cytiva) were washed with PBS+ 0.1% NP40 and DNA binding
buffer (10 mM Tris pH 8, 1M NaCl, 1 mM EDTA, 0.05% NP40). Beads and oligos
were incubated for 30 min in a rotation wheel at 4 °C. Beads were then washed once
with DNA-binding buffer and twice with protein incubation buffer (50 mM Tris
pH 8, 150 mM NaCl, 0.5% NP40, 1 mM DTT). Beads were then incubated with
500 μg of nuclear extracts together with DNA competitors (5 μg polydIdC and 5 μg
polydAdT) for 90 min in a rotation wheel at 4 °C. Beads were washed three times
with protein incubation buffer and twice with PBS. Then, 40 μl protein loading
buffer was added to the beads and the mixture was incubated 10 min at 95 °C.
Finally, samples were loaded on an SDS–PAGE gel for Western blotting.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE51 partner repository with the dataset identifier PXD025012
and processed data are provided in the Source Data file. ChIP-sequencing data can be
found under the reference number GSE169317 in the GEO database. Reference
H3K9me3 ChIP-seq was downloaded from the GEO database under reference number
GSE86814. Source data are provided with this paper.
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